RhApo2L/TRAIL
RhApo2L/TRAIL Uses, Dosage, Side Effects, Food Interaction and all others data.
RhApo2L/TRAIL has been used in trials studying the treatment of Colorectal Cancer, Non-Hodgkin's Lymphoma, and Metastatic Colorectal Cancer.
| Trade Name | RhApo2L/TRAIL |
| Generic | Dulanermin |
| Dulanermin Other Names | Apo2L/TRAIL, Dulanermin, rhApo2L/TRAIL |
| Type | |
| Formula | C871H1329N243O260S4 |
| Weight | 19492.7851 Da |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here RhApo2L/TRAIL
